BET proteins promote efficient murine leukemia virus integration at transcription start sites

Amit Sharma1, Ross C Larue, Matthew R Plumb

  • 1Center for Retrovirus Research, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.

Insights

Bromodomain and extraterminal domain (BET) proteins bind to Moloney murine leukemia virus (MLV) integrase, promoting its integration into the host genome. Inhibiting BET proteins reduces MLV integration at transcription start sites, suggesting a new therapeutic target.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Retroviral DNA integration into the host genome is a critical step in viral replication and gene therapy vector design.
  • Murine leukemia virus (MLV) preferentially integrates near transcription start sites, but the mechanism remains unclear.

Purpose of the Study:

  • To identify cellular factors involved in MLV integration targeting.
  • To elucidate the mechanism of MLV integration site selection.
  • To explore potential therapeutic strategies for safer MLV-based vectors.

Main Methods:

  • Co-immunoprecipitation and in vitro binding assays to identify MLV integrase interacting proteins.
  • Biochemical assays to assess the effect of BET proteins on MLV integration.
  • ChIP-sequencing to map BET protein binding sites.
  • Inhibition studies using JQ-1 small molecule and RNA interference to assess the role of BET proteins in MLV integration.

Main Results:

  • Bromodomain and extraterminal domain (BET) proteins (Brd2, -3, -4) were identified as binding partners of MLV integrase.
  • Recombinant Brd4 protein binds MLV integrase and enhances in vitro integration.
  • The BET inhibitor JQ-1 impaired MLV integration in infected cells.
  • Significant positive correlation was observed between BET protein binding sites and MLV integration sites.
  • Antagonism of BET proteins reduced MLV integration frequency at transcription start sites.

Conclusions:

  • BET proteins are crucial for the efficiency and targeting of MLV integration.
  • BET proteins play a significant role in directing MLV DNA to transcription start sites.
  • Targeting BET proteins offers a potential strategy for developing safer MLV-based gene therapy vectors.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...